Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 13 studies | 31% ± 12% | |
| oligodendrocyte | 11 studies | 28% ± 10% | |
| oligodendrocyte precursor cell | 7 studies | 33% ± 13% | |
| epithelial cell of proximal tubule | 5 studies | 29% ± 8% | |
| neural crest cell | 3 studies | 21% ± 2% | |
| epithelial cell | 3 studies | 30% ± 14% | |
| glutamatergic neuron | 3 studies | 23% ± 6% | |
| hepatocyte | 3 studies | 40% ± 20% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 25% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 98% | 7369.23 | 2601 / 2642 | 100% | 427.15 | 703 / 705 |
| adrenal gland | 99% | 6627.14 | 255 / 258 | 83% | 85.25 | 192 / 230 |
| liver | 100% | 6735.83 | 225 / 226 | 80% | 97.61 | 326 / 406 |
| skin | 99% | 7080.82 | 1787 / 1809 | 74% | 98.43 | 347 / 472 |
| stomach | 58% | 1171.63 | 210 / 359 | 78% | 74.81 | 223 / 286 |
| esophagus | 38% | 1122.60 | 551 / 1445 | 92% | 103.91 | 168 / 183 |
| pancreas | 100% | 4048.88 | 328 / 328 | 22% | 12.87 | 40 / 178 |
| kidney | 87% | 4902.34 | 77 / 89 | 28% | 26.03 | 255 / 901 |
| prostate | 23% | 357.97 | 57 / 245 | 84% | 58.97 | 423 / 502 |
| ovary | 9% | 216.80 | 16 / 180 | 99% | 211.94 | 424 / 430 |
| bladder | 33% | 526.90 | 7 / 21 | 71% | 62.84 | 356 / 504 |
| ureter | 0% | 0 | 0 / 0 | 100% | 57.20 | 1 / 1 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 103.25 | 44 / 45 |
| uterus | 8% | 251.20 | 13 / 170 | 84% | 87.90 | 387 / 459 |
| lung | 19% | 422.63 | 111 / 578 | 72% | 84.64 | 833 / 1155 |
| intestine | 10% | 198.19 | 93 / 966 | 81% | 84.45 | 426 / 527 |
| thymus | 28% | 646.91 | 181 / 653 | 32% | 36.78 | 193 / 605 |
| eye | 0% | 0 | 0 / 0 | 48% | 25.94 | 38 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 45% | 23.16 | 13 / 29 |
| breast | 12% | 302.78 | 56 / 459 | 23% | 23.38 | 255 / 1118 |
| spleen | 21% | 259.75 | 51 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 20% | 1011.81 | 182 / 929 | 0% | 0 | 0 / 0 |
| adipose | 18% | 397.96 | 221 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 5% | 106.00 | 64 / 1335 | 0% | 0 | 0 / 0 |
| heart | 2% | 33.76 | 20 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006564 | Biological process | L-serine biosynthetic process |
| GO_0008615 | Biological process | pyridoxine biosynthetic process |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0004648 | Molecular function | O-phospho-L-serine:2-oxoglutarate aminotransferase activity |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0030170 | Molecular function | pyridoxal phosphate binding |
| Gene name | PSAT1 |
| Protein name | Phosphoserine aminotransferase Phosphoserine aminotransferase (EC 2.6.1.52) (Phosphohydroxythreonine aminotransferase) (PSAT) |
| Synonyms | PSA |
| Description | FUNCTION: Involved in L-serine biosynthesis via the phosphorylated pathway, a three-step pathway converting the glycolytic intermediate 3-phospho-D-glycerate into L-serine. Catalyzes the second step, that is the pyridoxal 5'-phosphate-dependent transamination of 3-phosphohydroxypyruvate and L-glutamate to O-phosphoserine (OPS) and alpha-ketoglutarate. . |
| Accessions | ENST00000347159.6 [Q9Y617-2] Q9Y617 A9LS35 ENST00000376588.4 [Q9Y617-1] |
